Myeloproliferative Disorders [clinicaltrials_resource:971fd6618181ec973a01a5874591ca4f]
Evaluation of the Anti-CD-33 Immunotoxin Hum-195/rGel in Patients With Advanced Myeloid Malignancies [clinicaltrials:NCT00038051]clinicaltrials:NCT00074490clinicaltrials:NCT00075816Low-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the Blood [clinicaltrials:NCT00146055]TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD [clinicaltrials:NCT00185796]Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies [clinicaltrials:NCT00186342]Non-Myeloablative Allogeneic Transplant for Myelodysplastic Syndromes and Myeloproliferative Disorders [clinicaltrials:NCT00186576]Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic Leukemias [clinicaltrials:NCT00276926]A Safety Study of Lintuzumab in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome [clinicaltrials:NCT00283114]clinicaltrials:NCT00295880clinicaltrials:NCT00305682clinicaltrials:NCT00361140clinicaltrials:NCT00452023clinicaltrials:NCT00499668Unrelated Stem Cell Transplantation for Adults With Hematopoietic Disorders [clinicaltrials:NCT00511537]A Safety Study of XL019 in Adults With Myelofibrosis [clinicaltrials:NCT00522574]Investigation of the Cylex® ImmuKnow® Assay [clinicaltrials:NCT00569842]clinicaltrials:NCT00578539A Phase 1/2 Study of Oral SB1518 in Subjects With Chronic Idiopathic Myelofibrosis [clinicaltrials:NCT00745550]clinicaltrials:NCT00787761clinicaltrials:NCT00827099Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias [clinicaltrials:NCT00852709]STA-9090 for Treatment of AML, CML, MDS and Myeloproliferative Disorders [clinicaltrials:NCT00858572]JAK-STAT Signalling Pathway in Familial Myeloproliferative Disorders [clinicaltrials:NCT00873574]Minor Histocompatibility Vaccination After Allogeneic Stem Cell Transplantation for Advanced Hematologic Malignancies [clinicaltrials:NCT00943293]Efficacy and Safety of a Donor Lymphocyte Preparation Depleted of Functional Host Alloreactive T-cells (ATIR) in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor [clinicaltrials:NCT00967343]MSC and HSC Coinfusion in Mismatched Minitransplants [clinicaltrials:NCT01045382]A Study in Myeloproliferative Disorders [clinicaltrials:NCT01134120]B-Receptor Signaling in Cardiomyopathy [clinicaltrials:NCT01135849]Investigation of Dysregulated Signaling in MPD Via Multiparameter Phospho-specific Flow Cytometry [clinicaltrials:NCT01144780]clinicaltrials:NCT01200498clinicaltrials:NCT01343368clinicaltrials:NCT01366612Post T-plant Infusion of Allogeneic Cytokine Induced Killer Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders [clinicaltrials:NCT01392989]clinicaltrials:NCT01413568Study With Intravenous Busulfan And Fludarabine Myeloablative Conditioning Regimen For HLA Identical Sibling Donor HSCT [clinicaltrials:NCT01683123]clinicaltrials:NCT01684150Pathogenesis of Hematologic Malignancies [clinicaltrials:NCT01728402]Screening for Pulmonary Vascular Changes in Patients With Chronic Myeloproliferative Diseases [clinicaltrials:NCT01787162]clinicaltrials:NCT01787552
condition [clinicaltrials_vocabulary:condition]
Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer [clinicaltrials:NCT00002504]clinicaltrials:NCT00002718Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer [clinicaltrials:NCT00002742]Interleukin-2 in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00002746]Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorders [clinicaltrials:NCT00002792]Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00002809]Decitabine in Treating Patients With Melanoma or Other Advanced Cancer [clinicaltrials:NCT00002980]Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer [clinicaltrials:NCT00003082]Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors [clinicaltrials:NCT00003107]clinicaltrials:NCT00003116Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00003243]Combination Chemotherapy in Treating Patients With Advanced Cancer [clinicaltrials:NCT00003331]clinicaltrials:NCT00003335clinicaltrials:NCT00003336Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer [clinicaltrials:NCT00003406]Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer [clinicaltrials:NCT00003408]Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer [clinicaltrials:NCT00003451]clinicaltrials:NCT00003593clinicaltrials:NCT00003600Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia [clinicaltrials:NCT00003619]Treatment for Chronic Pain in Patients With Advanced Cancer [clinicaltrials:NCT00003687]clinicaltrials:NCT00003816clinicaltrials:NCT00003838Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation [clinicaltrials:NCT00003887]Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease [clinicaltrials:NCT00003913]Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00003961]Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer [clinicaltrials:NCT00004036]12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder [clinicaltrials:NCT00004058]Bone Marrow Transplantation in Treating Patients With Multiple Myeloma, Chronic Phase Chronic Myelogenous Leukemia, or Agnogenic Myeloid Metaplasia [clinicaltrials:NCT00004181]Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00004232]506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment [clinicaltrials:NCT00004239]Sodium Salicylate in Treating Patients With Advanced Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Chronic Lymphocytic Leukemia [clinicaltrials:NCT00004245]EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer [clinicaltrials:NCT00004258]Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00004871]Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00004896]Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00004899]Stem Cell Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00004904]clinicaltrials:NCT00005622Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation [clinicaltrials:NCT00005641]clinicaltrials:NCT00005797
condition browse [clinicaltrials_vocabulary:condition-browse]
Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer [clinicaltrials:NCT00002504]clinicaltrials:NCT00002718Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer [clinicaltrials:NCT00002742]Interleukin-2 in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00002746]Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorders [clinicaltrials:NCT00002792]Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00002809]Decitabine in Treating Patients With Melanoma or Other Advanced Cancer [clinicaltrials:NCT00002980]Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer [clinicaltrials:NCT00003082]Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors [clinicaltrials:NCT00003107]clinicaltrials:NCT00003116Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00003243]Combination Chemotherapy in Treating Patients With Advanced Cancer [clinicaltrials:NCT00003331]clinicaltrials:NCT00003335clinicaltrials:NCT00003336Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer [clinicaltrials:NCT00003406]Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer [clinicaltrials:NCT00003408]Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer [clinicaltrials:NCT00003451]clinicaltrials:NCT00003593clinicaltrials:NCT00003600Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia [clinicaltrials:NCT00003619]Treatment for Chronic Pain in Patients With Advanced Cancer [clinicaltrials:NCT00003687]clinicaltrials:NCT00003816clinicaltrials:NCT00003838Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation [clinicaltrials:NCT00003887]Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease [clinicaltrials:NCT00003913]Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00003961]Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer [clinicaltrials:NCT00004036]12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder [clinicaltrials:NCT00004058]Bone Marrow Transplantation in Treating Patients With Multiple Myeloma, Chronic Phase Chronic Myelogenous Leukemia, or Agnogenic Myeloid Metaplasia [clinicaltrials:NCT00004181]Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00004232]506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment [clinicaltrials:NCT00004239]Sodium Salicylate in Treating Patients With Advanced Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Chronic Lymphocytic Leukemia [clinicaltrials:NCT00004245]EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer [clinicaltrials:NCT00004258]Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00004871]Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00004896]Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00004899]Stem Cell Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00004904]clinicaltrials:NCT00005622Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation [clinicaltrials:NCT00005641]clinicaltrials:NCT00005797
condition mesh [clinicaltrials_vocabulary:condition-mesh]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Myeloproliferative Disorders [clinicaltrials_resource:971fd6618181ec973a01a5874591ca4f]
Bio2RDF identifier
971fd6618181ec973a01a5874591ca4f
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:971fd6618181ec973a01a5874591ca4f
identifier
clinicaltrials_resource:971fd6618181ec973a01a5874591ca4f
title
Myeloproliferative Disorders
@en
type
label
Myeloproliferative Disorders [clinicaltrials_resource:971fd6618181ec973a01a5874591ca4f]
@en
Myeloproliferative Disorders